MC2172A1 - Compositions,procedes,dose quotidienne,solution,son procede de preparation et ses utilisations pour le traitement de maladies de carence en iode - Google Patents

Compositions,procedes,dose quotidienne,solution,son procede de preparation et ses utilisations pour le traitement de maladies de carence en iode

Info

Publication number
MC2172A1
MC2172A1 MC90@@D MC2172D MC2172A1 MC 2172 A1 MC2172 A1 MC 2172A1 MC 2172 D MC2172 D MC 2172D MC 2172 A1 MC2172 A1 MC 2172A1
Authority
MC
Monaco
Prior art keywords
iodine
treatment
solution
deficiency diseases
composition
Prior art date
Application number
MC90@@D
Other languages
English (en)
Inventor
R Ghent William
A Eskin Bernard
Original Assignee
R Ghent William
A Eskin Bernard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Ghent William, A Eskin Bernard filed Critical R Ghent William
Publication of MC2172A1 publication Critical patent/MC2172A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Developing Agents For Electrophotography (AREA)
MC90@@D 1989-01-03 1990-01-03 Compositions,procedes,dose quotidienne,solution,son procede de preparation et ses utilisations pour le traitement de maladies de carence en iode MC2172A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/292,968 US5171582A (en) 1985-07-31 1989-01-03 Treatment of iodine deficiency diseases
PCT/CA1990/000007 WO1990007339A1 (fr) 1989-01-03 1990-01-03 Traitement des maladies liees a une deficience iodique

Publications (1)

Publication Number Publication Date
MC2172A1 true MC2172A1 (fr) 1992-05-22

Family

ID=23127029

Family Applications (1)

Application Number Title Priority Date Filing Date
MC90@@D MC2172A1 (fr) 1989-01-03 1990-01-03 Compositions,procedes,dose quotidienne,solution,son procede de preparation et ses utilisations pour le traitement de maladies de carence en iode

Country Status (14)

Country Link
US (1) US5171582A (fr)
EP (1) EP0377266B1 (fr)
JP (1) JP2994741B2 (fr)
AT (1) ATE106738T1 (fr)
AU (1) AU639222B2 (fr)
BG (1) BG94738A (fr)
BR (1) BR9006990A (fr)
CA (1) CA1336889C (fr)
DE (1) DE68915987T2 (fr)
DK (1) DK128291A (fr)
ES (1) ES2057098T3 (fr)
HU (1) HUT57050A (fr)
MC (1) MC2172A1 (fr)
WO (1) WO1990007339A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US6019970A (en) * 1985-07-31 2000-02-01 Ghent William R. Treatment of iodine deficiency diseases
JPH06508105A (ja) * 1991-03-28 1994-09-14 ９４３０３８　オンタリオ　インコーポレイテッド 乾燥デンプン−ヨウ素医薬処方剤
US5910318A (en) * 1991-03-28 1999-06-08 943038 Ontario Inc. Treatment of iodine deficiency diseases
US5955101A (en) * 1991-03-28 1999-09-21 943038 Ontario Inc. Dry starch-iodine pharmaceutical formulations
EP0722727A1 (fr) * 1995-01-20 1996-07-24 Eli Lilly And Company Dérivés de la benzofuranne pour inhiber la fibrose utérine
US5554600A (en) * 1995-01-20 1996-09-10 Eli Lilly And Company Methods for inhibiting endometriosis
US5489587A (en) * 1995-01-20 1996-02-06 Eli Lilly And Company Benzofurans used to inhibit bone loss
US6238644B1 (en) 1997-09-03 2001-05-29 Wayne State University Method for treating and/or imaging breast cancer using radioactive iodide
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
AU2005274638A1 (en) * 2004-08-20 2006-02-23 Dennis Hardy O'dowd Method of detecting and treating allogenic cells responsible for endometriosis
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
AU2014343379B2 (en) 2013-11-04 2019-02-14 Uti Limited Partnership Methods and compositions for sustained immunotherapy
EP3291832B1 (fr) 2015-05-06 2025-09-03 UTI Limited Partnership Compositions de nanoparticules pour thérapie prolongée
CA3083748A1 (fr) 2017-11-29 2019-06-06 Uti Limited Partnership Methodes de traitement d'une maladie auto-immune

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384960A (en) * 1979-11-13 1983-05-24 Polley R D Iodine dispenser and method of dispensing iodine
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
FR2611733B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux

Also Published As

Publication number Publication date
US5171582A (en) 1992-12-15
JP2994741B2 (ja) 1999-12-27
HU900916D0 (en) 1991-10-28
JPH04503949A (ja) 1992-07-16
HUT57050A (en) 1991-11-28
ES2057098T3 (es) 1994-10-16
BG94738A (bg) 1993-12-24
DK128291D0 (da) 1991-07-01
DE68915987D1 (de) 1994-07-14
CA1336889C (fr) 1995-09-05
DK128291A (da) 1991-08-21
EP0377266A1 (fr) 1990-07-11
EP0377266B1 (fr) 1994-06-08
AU4819990A (en) 1990-08-01
AU639222B2 (en) 1993-07-22
ATE106738T1 (de) 1994-06-15
DE68915987T2 (de) 1995-01-12
BR9006990A (pt) 1991-11-12
WO1990007339A1 (fr) 1990-07-12

Similar Documents

Publication Publication Date Title
MC2172A1 (fr) Compositions,procedes,dose quotidienne,solution,son procede de preparation et ses utilisations pour le traitement de maladies de carence en iode
GB2314850B (en) Process for glucan preparation
FR2438478A1 (fr) Composition stable pour la remineralisation dentaire
EP0168831A3 (en) Tetrapyrrole compounds and process for the production of same and a pharmaceutical composition containing same
FR2633603B1 (fr) Trifluorure de cerium a nouvelles caracteristiques morphologiques et son procede d'obtention
PT77616B (en) Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same
SE8005580L (sv) Harvextkomposition och forfarande for dess framstellning
ES8605956A1 (es) Procedimiento para preparar una composicion antiacido
FR2442250A1 (fr) Compositions de verre et ciments auxquels sont incorporees ces compositions
PT74928A (en) New anti-thromboticum based on polysachatides method for its preparation and pharmaceutical compositions
FR2426057A1 (fr) Preparation de produits absorbants a base de carboxymethylcellulose, insolubles dans l'eau
MY8500407A (en) 2,6-dial koxybenzamides, process for their preparation compositions and these compounds for use in the treatment of psychotic discorders
EP0249248A3 (fr) Dérivés de purine
IE892094L (en) New strontium salt, process for the preparation thereof and¹pharmaceutical compositions containing it
DE3275204D1 (en) Process for the manufacture of soap powder
FR2388771A1 (fr) Platre obtenu a partir de phosphogypses et procede pour son obtention
NZ221066A (en) Trichokirin and derivatives
RO79426B1 (ro) Compozitie medicamentoasa pentru tratamentul unor neuroviroze
HU913009D0 (en) Method for producing inhibitors of calcium ingestion
ATE97639T1 (de) Verfahren fuer die wasseraufbereitung.
NO912528L (no) Behandling av sykdommer forbundet med jodmangel.
ES468435A1 (es) Procedimiento para la precipitacion y separacion del arseni-co de soluciones que contienen cobre
ATE111973T1 (de) Metallschützende zusammensetzungen, ihr herstellungsverfahren und metallschutzverfahren.
JPS53142315A (en) Manufacture of cu-ni-sn alloy material
JPS57116319A (en) Contamination preventing liquid for contact lens